Literature DB >> 17596764

Curative treatment of a pelvic side wall recurrence after conization for microinvasive cervical cancer stage IA1: a case report and review of the literature.

Konstantin J Dedes1, Miltiades Dedes, Zsuzsanna Varga, Dieter R Zimmermann, Daniel Fink, Mathias K Fehr.   

Abstract

BACKGROUND: For patients wishing to preserve fertility conization is regarded as an adequate treatment in cervical cancer stage IA1 without lymphovascular space involvement (LVSI). Reviewing case series with IA1 cervical cancers without LVSI, lymph node metastasis (LNM) is present in 0.5%.
MATERIALS AND METHODS: We pr esent a case of a 34-year-old patient treated with conization for squamous cervical cancer invading 1.2 mm without LVSI and horizontal extension of 6 mm (IA1).
RESULTS: At a routine postpartum examination after an uneventful pregnancy, a 5-cm pelvic mass was noted at the right pelvic wall. Intraoperative evaluation revealed a LNM which was resected, and postoperative pelvic chemoradiotherapy was performed. The patient remains recurrence-free 84 months after conization and 73 months after resection of the recurrence.
CONCLUSIONS: Occurrence of LNM in IA1 cervical cancers is very rare, but if early diagnosed curative treatment is possible.

Entities:  

Mesh:

Year:  2007        PMID: 17596764     DOI: 10.1097/lgt.0b013e3180316720

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  2 in total

1.  Aspects of Therapy for Cervical Cancer in Germany 2012 - Results from a Survey of German Gynaecological Hospitals.

Authors:  M Mangler; N Zech; A Schneider; C Köhler; S Marnitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-03       Impact factor: 2.915

2.  Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China.

Authors:  Qiuhong Qian; Jiaxin Yang; Dongyan Cao; Yan You; Jie Chen; Keng Shen
Journal:  J Gynecol Oncol       Date:  2014-06-18       Impact factor: 4.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.